SlideShare une entreprise Scribd logo
1  sur  16
Copyrighted 2013, Compliance
Insight, Inc.
Top 22 Tips:
Writing for FDA Compliance
Troy Fugate
Compliance Insight, Inc.
Investigator, Auditor
Copyrighted 2013, Compliance
Insight, Inc.
This presentation will cover…
• Why we document?
• If we don’t document or document poorly,
what are the consequences.
• Good writing overview
• Report writing tips
Copyrighted 2013, Compliance
Insight, Inc.
Why document?
• It is the law!
– Thou shall document
• 211.192
– “A written record of the investigation
shall be made and shall include the
conclusions and follow-up”
• Guidance “Investigating OOS Test
Results for Pharmaceutical
Production”
Copyrighted 2013, Compliance
Insight, Inc.
Formal Documentation
• The goal is to clearly describe:
– The issue or problem
– The paths taken during the
investigation
– CAPA
– Conclusion
• Prevents errors due to oral
communication
• Prevents errors due to informal
documentation
Copyrighted 2013, Compliance
Insight, Inc.
Poor Documentation
• Examples
– None
– Confusing, unclear, vague
• Consequences
– Release bad product
– Reject good product
– Legal issues
– Reputation
• FDA
• Public
Copyrighted 2013, Compliance
Insight, Inc.
What are you going to document?
• All GMP related operations
– Manufacturing
– Packaging
– Testing
– Etc.
• Investigations
• Complaints
You are going to document
just about everything in
pharmaceutical operations
– especially dealing with
quality!!!!!
Copyrighted 2013, Compliance
Insight, Inc.
The Top 22 Tips…
1. Be clear, concise and timely
2. Clearly summarize the issue
3. Include all pertinent items found during
the investigation
4. Have a conclusion
5. Indicate CAPA
6. Be approved – QA ++++
7. Be communicated to the appropriate
people
If you don’t have a
conclusion, the FDA
will make one for you!
Copyrighted 2013, Compliance
Insight, Inc.
The Top 22 Tips…
8. Not assume anything
– The reader may not know
• The process (or know if very well)
• The product
• The history
8. Use charts, tables, graphs
9. Do Not use slang, jargon
10.Backup findings with evidence, data
11.Do Not exaggerate
Copyrighted 2013, Compliance
Insight, Inc.
The Top 22 Tips…
13.State the scope of the problem or issue
14.Outline the root cause
15.Indicate CAPA
– Systemic approach
13.Flows well
– Paragraphs connected via some form of
thought process
13.Use bullet points as necessary
Copyrighted 2013, Compliance
Insight, Inc.
The Top 22 Tips…
18.List key dates and times
19.Timeline of the investigation
20.Contain copies of reference data
21.Contain copies of CAPA items
– Training
– Purchases
– Employee issues – NO (this is personal)
18.Be all inclusive to the incident
– Don’t stop just because you “think” you found the
problem
Copyrighted 2013, Compliance
Insight, Inc.
How to write
• Place yourself in the background
• Use nouns and verbs
– Minimal use of adjectives and adverbs
• Revise, revise, revise
– Let others not involved with the issue read the
report
– Remember, the next person to read this
report may be the FDA
Copyrighted 2013, Compliance
Insight, Inc.
How to write
• Avoid “local” or technologically advanced
wording
• Do not inject opinion
• Spell out abbreviations
• Be specific
– The product didn’t meet specifications.
– Better: Product Fugatium Bromide, Tablets,
10 mg, did not meet potency specifications of
92 – 102% as dictated in the USP. The
results were as follows:
Copyrighted 2013, Compliance
Insight, Inc.
How to write
• Select a format and stick with it
• Select a report format
– Introduction
– Outline of investigation
– Summary of investigation
– Conclusion
– CAPA
Copyrighted 2013, Compliance
Insight, Inc.
How to write
• Put statements in a positive form
• Use definite, specific language
• Don’t include needless wording or
statements
• Check your data (calculation errors have
resulted in further problems)
Copyrighted 2013, Compliance
Insight, Inc.
How to write
• The next reader will probably be an
auditor
• Begin with the end in mind
– (i.e. What is your goal?)
• Include all areas of the investigation
– Even those that resulted in “no issues noted”
• Indicate results, expected ranges and
specifications (internal, NDA, ANDA, USP)
For More Information or Help…
• Give us a call at:
– 513-860-3512
– www.Compliance-Insight.com
– FDATrainingTeam@compliance-insight.com
– Free consultation by phone
Copyrighted 2013, Compliance
Insight, Inc.

Contenu connexe

Tendances

ICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk ManagementICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk Managementmuna_ali
 
Manufacturing planning and self inspection in pharmaceutical industries
Manufacturing planning and self inspection in pharmaceutical industriesManufacturing planning and self inspection in pharmaceutical industries
Manufacturing planning and self inspection in pharmaceutical industriesSumita Sahoo
 
Pharmaceutical Quality System
Pharmaceutical Quality SystemPharmaceutical Quality System
Pharmaceutical Quality SystemAnkur Saikia
 
Self inspection
Self inspectionSelf inspection
Self inspectionBangaluru
 
Six system inspection model
Six system inspection modelSix system inspection model
Six system inspection modelDhrutiPatel61
 
QUALITY BY DESIGN PPT BY GIRIJA
QUALITY BY DESIGN PPT BY GIRIJAQUALITY BY DESIGN PPT BY GIRIJA
QUALITY BY DESIGN PPT BY GIRIJAGirija Dandu
 
AUDITING OF QUALITY ASSURANCE AND ENGINEERING DEPARTMENT.pptx
AUDITING OF QUALITY ASSURANCE AND ENGINEERING DEPARTMENT.pptxAUDITING OF QUALITY ASSURANCE AND ENGINEERING DEPARTMENT.pptx
AUDITING OF QUALITY ASSURANCE AND ENGINEERING DEPARTMENT.pptxShankar Maind Patil
 
Line clearence by Phani venkata sai ram
Line clearence by Phani venkata sai ramLine clearence by Phani venkata sai ram
Line clearence by Phani venkata sai ramPhani Venkata Sai Ram
 
Issue facing modern drug packaging, selection & evaluation of pharmaceuti...
Issue facing modern drug packaging, selection & evaluation of pharmaceuti...Issue facing modern drug packaging, selection & evaluation of pharmaceuti...
Issue facing modern drug packaging, selection & evaluation of pharmaceuti...HEALY LAD
 
Auditing of vendors and production department
Auditing of vendors and production departmentAuditing of vendors and production department
Auditing of vendors and production departmentshreyashChaudhari6
 
Gmp Auditor Training Course
Gmp Auditor   Training CourseGmp Auditor   Training Course
Gmp Auditor Training Coursepiyush64173
 
GMP - GOOD DOCUMENTATION PRACTICES
GMP - GOOD DOCUMENTATION PRACTICESGMP - GOOD DOCUMENTATION PRACTICES
GMP - GOOD DOCUMENTATION PRACTICESOmkar Phutane
 
AUDITING OF AUALITY ASSURANCE AND ENGINEERING DEPARTMENT
AUDITING OF AUALITY ASSURANCE AND ENGINEERING DEPARTMENT AUDITING OF AUALITY ASSURANCE AND ENGINEERING DEPARTMENT
AUDITING OF AUALITY ASSURANCE AND ENGINEERING DEPARTMENT HemlataMore3
 

Tendances (20)

ICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk ManagementICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk Management
 
4. capa industry basics - final
4. capa   industry basics - final4. capa   industry basics - final
4. capa industry basics - final
 
FDA Audit - The Do and Don't List
FDA Audit - The Do and Don't ListFDA Audit - The Do and Don't List
FDA Audit - The Do and Don't List
 
Manufacturing planning and self inspection in pharmaceutical industries
Manufacturing planning and self inspection in pharmaceutical industriesManufacturing planning and self inspection in pharmaceutical industries
Manufacturing planning and self inspection in pharmaceutical industries
 
Good practices in production
Good practices in productionGood practices in production
Good practices in production
 
Pharmaceutical Documentation
Pharmaceutical DocumentationPharmaceutical Documentation
Pharmaceutical Documentation
 
ICH Q7 GMP for API
ICH Q7 GMP for APIICH Q7 GMP for API
ICH Q7 GMP for API
 
Pharmaceutical Quality System
Pharmaceutical Quality SystemPharmaceutical Quality System
Pharmaceutical Quality System
 
Self inspection
Self inspectionSelf inspection
Self inspection
 
Six system inspection model
Six system inspection modelSix system inspection model
Six system inspection model
 
QUALITY BY DESIGN PPT BY GIRIJA
QUALITY BY DESIGN PPT BY GIRIJAQUALITY BY DESIGN PPT BY GIRIJA
QUALITY BY DESIGN PPT BY GIRIJA
 
AUDITING OF QUALITY ASSURANCE AND ENGINEERING DEPARTMENT.pptx
AUDITING OF QUALITY ASSURANCE AND ENGINEERING DEPARTMENT.pptxAUDITING OF QUALITY ASSURANCE AND ENGINEERING DEPARTMENT.pptx
AUDITING OF QUALITY ASSURANCE AND ENGINEERING DEPARTMENT.pptx
 
Line clearence by Phani venkata sai ram
Line clearence by Phani venkata sai ramLine clearence by Phani venkata sai ram
Line clearence by Phani venkata sai ram
 
Issue facing modern drug packaging, selection & evaluation of pharmaceuti...
Issue facing modern drug packaging, selection & evaluation of pharmaceuti...Issue facing modern drug packaging, selection & evaluation of pharmaceuti...
Issue facing modern drug packaging, selection & evaluation of pharmaceuti...
 
Auditing of vendors and production department
Auditing of vendors and production departmentAuditing of vendors and production department
Auditing of vendors and production department
 
Gmp Auditor Training Course
Gmp Auditor   Training CourseGmp Auditor   Training Course
Gmp Auditor Training Course
 
Mfr
MfrMfr
Mfr
 
Packaging material vendor audit
Packaging material vendor auditPackaging material vendor audit
Packaging material vendor audit
 
GMP - GOOD DOCUMENTATION PRACTICES
GMP - GOOD DOCUMENTATION PRACTICESGMP - GOOD DOCUMENTATION PRACTICES
GMP - GOOD DOCUMENTATION PRACTICES
 
AUDITING OF AUALITY ASSURANCE AND ENGINEERING DEPARTMENT
AUDITING OF AUALITY ASSURANCE AND ENGINEERING DEPARTMENT AUDITING OF AUALITY ASSURANCE AND ENGINEERING DEPARTMENT
AUDITING OF AUALITY ASSURANCE AND ENGINEERING DEPARTMENT
 

Similaire à Top 22 Tips: Writing For FDA Compliance

REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENTREGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENTMichael Swit
 
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENTREGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENTMichael Swit
 
Drug Development in Today's Regulatory Environment
Drug Development in Today's Regulatory EnvironmentDrug Development in Today's Regulatory Environment
Drug Development in Today's Regulatory EnvironmentMichael Swit
 
Best Audit Practices: The Top 10 Auditing Mistakes Companies Make
Best Audit Practices: The Top 10 Auditing Mistakes Companies MakeBest Audit Practices: The Top 10 Auditing Mistakes Companies Make
Best Audit Practices: The Top 10 Auditing Mistakes Companies MakeSafetyChain Software
 
Business Communication TodayFourteenth EditionChapter 13Fi.docx
Business Communication TodayFourteenth EditionChapter 13Fi.docxBusiness Communication TodayFourteenth EditionChapter 13Fi.docx
Business Communication TodayFourteenth EditionChapter 13Fi.docxfelicidaddinwoodie
 
Business Communication TodayFourteenth EditionChapter 13Fi.docx
Business Communication TodayFourteenth EditionChapter 13Fi.docxBusiness Communication TodayFourteenth EditionChapter 13Fi.docx
Business Communication TodayFourteenth EditionChapter 13Fi.docxhumphrieskalyn
 
Ensuring FDA Regulatory Success for Biomedical Companies
Ensuring FDA Regulatory Success for Biomedical CompaniesEnsuring FDA Regulatory Success for Biomedical Companies
Ensuring FDA Regulatory Success for Biomedical CompaniesMichael Swit
 
Lecture 8 Resources and Costs.pptx
Lecture 8 Resources and Costs.pptxLecture 8 Resources and Costs.pptx
Lecture 8 Resources and Costs.pptxGelmelinaLeaLepitenH
 
Testing & Optimization - A Deeper Look
Testing & Optimization - A Deeper LookTesting & Optimization - A Deeper Look
Testing & Optimization - A Deeper LookCaleb Whitmore
 
5 Proven Strategies For a Successful Analytics Product Launch
5 Proven Strategies For a Successful Analytics Product Launch5 Proven Strategies For a Successful Analytics Product Launch
5 Proven Strategies For a Successful Analytics Product LaunchGoodData
 
Testing the unknown: the art and science of working with hypothesis
Testing the unknown: the art and science of working with hypothesisTesting the unknown: the art and science of working with hypothesis
Testing the unknown: the art and science of working with hypothesisArdita Karaj
 
Regulatory Considerations in Product Development
Regulatory Considerations in Product DevelopmentRegulatory Considerations in Product Development
Regulatory Considerations in Product DevelopmentMichael Swit
 
FDA Inspections are Different from ISO Audits, So Don't Treat Them the Same -...
FDA Inspections are Different from ISO Audits, So Don't Treat Them the Same -...FDA Inspections are Different from ISO Audits, So Don't Treat Them the Same -...
FDA Inspections are Different from ISO Audits, So Don't Treat Them the Same -...April Bright
 
, please see the feedback within your paper and in the scoring rub.docx
, please see the feedback within your paper and in the scoring rub.docx, please see the feedback within your paper and in the scoring rub.docx
, please see the feedback within your paper and in the scoring rub.docxmadlynplamondon
 
Exaudio, llc Background + MR capabilities
Exaudio, llc Background + MR capabilitiesExaudio, llc Background + MR capabilities
Exaudio, llc Background + MR capabilitiesExaudio
 

Similaire à Top 22 Tips: Writing For FDA Compliance (20)

REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENTREGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
 
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENTREGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
REGULATORY AND OTHER PITFALLS IN DRUG DEVELOPMENT
 
Drug Development in Today's Regulatory Environment
Drug Development in Today's Regulatory EnvironmentDrug Development in Today's Regulatory Environment
Drug Development in Today's Regulatory Environment
 
Best Audit Practices: The Top 10 Auditing Mistakes Companies Make
Best Audit Practices: The Top 10 Auditing Mistakes Companies MakeBest Audit Practices: The Top 10 Auditing Mistakes Companies Make
Best Audit Practices: The Top 10 Auditing Mistakes Companies Make
 
ch01.ppt
ch01.pptch01.ppt
ch01.ppt
 
Pai
PaiPai
Pai
 
Quality audit plan
Quality audit planQuality audit plan
Quality audit plan
 
Business Communication TodayFourteenth EditionChapter 13Fi.docx
Business Communication TodayFourteenth EditionChapter 13Fi.docxBusiness Communication TodayFourteenth EditionChapter 13Fi.docx
Business Communication TodayFourteenth EditionChapter 13Fi.docx
 
Business Communication TodayFourteenth EditionChapter 13Fi.docx
Business Communication TodayFourteenth EditionChapter 13Fi.docxBusiness Communication TodayFourteenth EditionChapter 13Fi.docx
Business Communication TodayFourteenth EditionChapter 13Fi.docx
 
Mike Roe Creating Client Value
Mike Roe Creating Client ValueMike Roe Creating Client Value
Mike Roe Creating Client Value
 
Ensuring FDA Regulatory Success for Biomedical Companies
Ensuring FDA Regulatory Success for Biomedical CompaniesEnsuring FDA Regulatory Success for Biomedical Companies
Ensuring FDA Regulatory Success for Biomedical Companies
 
Lecture 8 Resources and Costs.pptx
Lecture 8 Resources and Costs.pptxLecture 8 Resources and Costs.pptx
Lecture 8 Resources and Costs.pptx
 
Documentation: First & Last Exit in GMP
Documentation: First & Last Exit in GMP Documentation: First & Last Exit in GMP
Documentation: First & Last Exit in GMP
 
Testing & Optimization - A Deeper Look
Testing & Optimization - A Deeper LookTesting & Optimization - A Deeper Look
Testing & Optimization - A Deeper Look
 
5 Proven Strategies For a Successful Analytics Product Launch
5 Proven Strategies For a Successful Analytics Product Launch5 Proven Strategies For a Successful Analytics Product Launch
5 Proven Strategies For a Successful Analytics Product Launch
 
Testing the unknown: the art and science of working with hypothesis
Testing the unknown: the art and science of working with hypothesisTesting the unknown: the art and science of working with hypothesis
Testing the unknown: the art and science of working with hypothesis
 
Regulatory Considerations in Product Development
Regulatory Considerations in Product DevelopmentRegulatory Considerations in Product Development
Regulatory Considerations in Product Development
 
FDA Inspections are Different from ISO Audits, So Don't Treat Them the Same -...
FDA Inspections are Different from ISO Audits, So Don't Treat Them the Same -...FDA Inspections are Different from ISO Audits, So Don't Treat Them the Same -...
FDA Inspections are Different from ISO Audits, So Don't Treat Them the Same -...
 
, please see the feedback within your paper and in the scoring rub.docx
, please see the feedback within your paper and in the scoring rub.docx, please see the feedback within your paper and in the scoring rub.docx
, please see the feedback within your paper and in the scoring rub.docx
 
Exaudio, llc Background + MR capabilities
Exaudio, llc Background + MR capabilitiesExaudio, llc Background + MR capabilities
Exaudio, llc Background + MR capabilities
 

Plus de Compliance Insight, Inc. (14)

July 2015
July 2015July 2015
July 2015
 
GCP Overview by Compliance Insight, Inc.
GCP Overview by Compliance Insight, Inc.GCP Overview by Compliance Insight, Inc.
GCP Overview by Compliance Insight, Inc.
 
FDA audit series part 5, dealing with the 483 or Warning Letter
FDA audit series   part 5, dealing with the 483 or Warning LetterFDA audit series   part 5, dealing with the 483 or Warning Letter
FDA audit series part 5, dealing with the 483 or Warning Letter
 
FDA audit series part 4, the closeout
FDA audit series   part 4, the closeoutFDA audit series   part 4, the closeout
FDA audit series part 4, the closeout
 
Fda audit series part 3, while the fda is there
Fda audit series   part 3, while the fda is  thereFda audit series   part 3, while the fda is  there
Fda audit series part 3, while the fda is there
 
FDA audit series part 2, what to do when the FDA arrives
FDA audit series   part 2, what to do when the FDA arrivesFDA audit series   part 2, what to do when the FDA arrives
FDA audit series part 2, what to do when the FDA arrives
 
FDA audit series part 1, Preparing for the Audit
FDA audit series   part 1, Preparing for the AuditFDA audit series   part 1, Preparing for the Audit
FDA audit series part 1, Preparing for the Audit
 
About Compliance Insight Inc.
About Compliance Insight Inc.About Compliance Insight Inc.
About Compliance Insight Inc.
 
FDA 483 observations in the lab
FDA 483 observations in the labFDA 483 observations in the lab
FDA 483 observations in the lab
 
Basics of FDA GMP Training
Basics of FDA GMP TrainingBasics of FDA GMP Training
Basics of FDA GMP Training
 
21 cfr, parts 210 211
21 cfr, parts 210 21121 cfr, parts 210 211
21 cfr, parts 210 211
 
FDA Warning Letter
FDA Warning LetterFDA Warning Letter
FDA Warning Letter
 
FDA 483
FDA 483FDA 483
FDA 483
 
Fda Inspection
Fda InspectionFda Inspection
Fda Inspection
 

Dernier

International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...ssuserf63bd7
 
Send Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.comSendBig4
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCRashishs7044
 
Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...Americas Got Grants
 
Entrepreneurship lessons in Philippines
Entrepreneurship lessons in  PhilippinesEntrepreneurship lessons in  Philippines
Entrepreneurship lessons in PhilippinesDavidSamuel525586
 
Organizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessOrganizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessSeta Wicaksana
 
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptx
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptxThe-Ethical-issues-ghhhhhhhhjof-Byjus.pptx
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptxmbikashkanyari
 
Appkodes Tinder Clone Script with Customisable Solutions.pptx
Appkodes Tinder Clone Script with Customisable Solutions.pptxAppkodes Tinder Clone Script with Customisable Solutions.pptx
Appkodes Tinder Clone Script with Customisable Solutions.pptxappkodes
 
Chapter 9 PPT 4th edition.pdf internal audit
Chapter 9 PPT 4th edition.pdf internal auditChapter 9 PPT 4th edition.pdf internal audit
Chapter 9 PPT 4th edition.pdf internal auditNhtLNguyn9
 
Guide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDFGuide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDFChandresh Chudasama
 
APRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfAPRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfRbc Rbcua
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCRashishs7044
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfrichard876048
 
8447779800, Low rate Call girls in Saket Delhi NCR
8447779800, Low rate Call girls in Saket Delhi NCR8447779800, Low rate Call girls in Saket Delhi NCR
8447779800, Low rate Call girls in Saket Delhi NCRashishs7044
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationAnamaria Contreras
 
Market Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMarket Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMintel Group
 
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdfNewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdfKhaled Al Awadi
 
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City GurgaonCall Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaoncallgirls2057
 

Dernier (20)

International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...
 
Send Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.comSend Files | Sendbig.com
Send Files | Sendbig.comSend Files | Sendbig.com
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
 
Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...Church Building Grants To Assist With New Construction, Additions, And Restor...
Church Building Grants To Assist With New Construction, Additions, And Restor...
 
Entrepreneurship lessons in Philippines
Entrepreneurship lessons in  PhilippinesEntrepreneurship lessons in  Philippines
Entrepreneurship lessons in Philippines
 
Organizational Structure Running A Successful Business
Organizational Structure Running A Successful BusinessOrganizational Structure Running A Successful Business
Organizational Structure Running A Successful Business
 
No-1 Call Girls In Goa 93193 VIP 73153 Escort service In North Goa Panaji, Ca...
No-1 Call Girls In Goa 93193 VIP 73153 Escort service In North Goa Panaji, Ca...No-1 Call Girls In Goa 93193 VIP 73153 Escort service In North Goa Panaji, Ca...
No-1 Call Girls In Goa 93193 VIP 73153 Escort service In North Goa Panaji, Ca...
 
Call Us ➥9319373153▻Call Girls In North Goa
Call Us ➥9319373153▻Call Girls In North GoaCall Us ➥9319373153▻Call Girls In North Goa
Call Us ➥9319373153▻Call Girls In North Goa
 
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptx
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptxThe-Ethical-issues-ghhhhhhhhjof-Byjus.pptx
The-Ethical-issues-ghhhhhhhhjof-Byjus.pptx
 
Appkodes Tinder Clone Script with Customisable Solutions.pptx
Appkodes Tinder Clone Script with Customisable Solutions.pptxAppkodes Tinder Clone Script with Customisable Solutions.pptx
Appkodes Tinder Clone Script with Customisable Solutions.pptx
 
Chapter 9 PPT 4th edition.pdf internal audit
Chapter 9 PPT 4th edition.pdf internal auditChapter 9 PPT 4th edition.pdf internal audit
Chapter 9 PPT 4th edition.pdf internal audit
 
Guide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDFGuide Complete Set of Residential Architectural Drawings PDF
Guide Complete Set of Residential Architectural Drawings PDF
 
APRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfAPRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdf
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
 
Innovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdfInnovation Conference 5th March 2024.pdf
Innovation Conference 5th March 2024.pdf
 
8447779800, Low rate Call girls in Saket Delhi NCR
8447779800, Low rate Call girls in Saket Delhi NCR8447779800, Low rate Call girls in Saket Delhi NCR
8447779800, Low rate Call girls in Saket Delhi NCR
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement Presentation
 
Market Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 EditionMarket Sizes Sample Report - 2024 Edition
Market Sizes Sample Report - 2024 Edition
 
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdfNewBase  19 April  2024  Energy News issue - 1717 by Khaled Al Awadi.pdf
NewBase 19 April 2024 Energy News issue - 1717 by Khaled Al Awadi.pdf
 
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City GurgaonCall Us 📲8800102216📞 Call Girls In DLF City Gurgaon
Call Us 📲8800102216📞 Call Girls In DLF City Gurgaon
 

Top 22 Tips: Writing For FDA Compliance

  • 1. Copyrighted 2013, Compliance Insight, Inc. Top 22 Tips: Writing for FDA Compliance Troy Fugate Compliance Insight, Inc. Investigator, Auditor
  • 2. Copyrighted 2013, Compliance Insight, Inc. This presentation will cover… • Why we document? • If we don’t document or document poorly, what are the consequences. • Good writing overview • Report writing tips
  • 3. Copyrighted 2013, Compliance Insight, Inc. Why document? • It is the law! – Thou shall document • 211.192 – “A written record of the investigation shall be made and shall include the conclusions and follow-up” • Guidance “Investigating OOS Test Results for Pharmaceutical Production”
  • 4. Copyrighted 2013, Compliance Insight, Inc. Formal Documentation • The goal is to clearly describe: – The issue or problem – The paths taken during the investigation – CAPA – Conclusion • Prevents errors due to oral communication • Prevents errors due to informal documentation
  • 5. Copyrighted 2013, Compliance Insight, Inc. Poor Documentation • Examples – None – Confusing, unclear, vague • Consequences – Release bad product – Reject good product – Legal issues – Reputation • FDA • Public
  • 6. Copyrighted 2013, Compliance Insight, Inc. What are you going to document? • All GMP related operations – Manufacturing – Packaging – Testing – Etc. • Investigations • Complaints You are going to document just about everything in pharmaceutical operations – especially dealing with quality!!!!!
  • 7. Copyrighted 2013, Compliance Insight, Inc. The Top 22 Tips… 1. Be clear, concise and timely 2. Clearly summarize the issue 3. Include all pertinent items found during the investigation 4. Have a conclusion 5. Indicate CAPA 6. Be approved – QA ++++ 7. Be communicated to the appropriate people If you don’t have a conclusion, the FDA will make one for you!
  • 8. Copyrighted 2013, Compliance Insight, Inc. The Top 22 Tips… 8. Not assume anything – The reader may not know • The process (or know if very well) • The product • The history 8. Use charts, tables, graphs 9. Do Not use slang, jargon 10.Backup findings with evidence, data 11.Do Not exaggerate
  • 9. Copyrighted 2013, Compliance Insight, Inc. The Top 22 Tips… 13.State the scope of the problem or issue 14.Outline the root cause 15.Indicate CAPA – Systemic approach 13.Flows well – Paragraphs connected via some form of thought process 13.Use bullet points as necessary
  • 10. Copyrighted 2013, Compliance Insight, Inc. The Top 22 Tips… 18.List key dates and times 19.Timeline of the investigation 20.Contain copies of reference data 21.Contain copies of CAPA items – Training – Purchases – Employee issues – NO (this is personal) 18.Be all inclusive to the incident – Don’t stop just because you “think” you found the problem
  • 11. Copyrighted 2013, Compliance Insight, Inc. How to write • Place yourself in the background • Use nouns and verbs – Minimal use of adjectives and adverbs • Revise, revise, revise – Let others not involved with the issue read the report – Remember, the next person to read this report may be the FDA
  • 12. Copyrighted 2013, Compliance Insight, Inc. How to write • Avoid “local” or technologically advanced wording • Do not inject opinion • Spell out abbreviations • Be specific – The product didn’t meet specifications. – Better: Product Fugatium Bromide, Tablets, 10 mg, did not meet potency specifications of 92 – 102% as dictated in the USP. The results were as follows:
  • 13. Copyrighted 2013, Compliance Insight, Inc. How to write • Select a format and stick with it • Select a report format – Introduction – Outline of investigation – Summary of investigation – Conclusion – CAPA
  • 14. Copyrighted 2013, Compliance Insight, Inc. How to write • Put statements in a positive form • Use definite, specific language • Don’t include needless wording or statements • Check your data (calculation errors have resulted in further problems)
  • 15. Copyrighted 2013, Compliance Insight, Inc. How to write • The next reader will probably be an auditor • Begin with the end in mind – (i.e. What is your goal?) • Include all areas of the investigation – Even those that resulted in “no issues noted” • Indicate results, expected ranges and specifications (internal, NDA, ANDA, USP)
  • 16. For More Information or Help… • Give us a call at: – 513-860-3512 – www.Compliance-Insight.com – FDATrainingTeam@compliance-insight.com – Free consultation by phone Copyrighted 2013, Compliance Insight, Inc.